Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
10.1016/j.neuron.2007.01.010 Neuron 43 YoungG
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medicines originally developed for type 2 diabetes management but increasingly recognised for their effects on body composition, including visceral fat reduction
C.BarravieraB.PimentaD
This study aims to explore this gap by utilizing data from the large community-based database, TriNetX, to investigate the association between GLP-1 RA use and the risk of psychiatric diseases, including major depression, anxiety and suicidal behaviour in patients with obesity
Tarsal Tunnel Syndrome Tarsal tunnel syndrome compression of the posterior tibial nerve is frequently confused with plantar fasciitis, neuropathy, or other conditions
New research is showing real, measurable benefits, and in late 2024 the FDA approved a related GLP-1 drug specifically for the condition
